Mediolanum International Funds Ltd Buys 26,234 Shares of The Clorox Company $CLX

Mediolanum International Funds Ltd boosted its stake in shares of The Clorox Company (NYSE:CLX) by 949.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 28,998 shares of the company’s stock after purchasing an additional 26,234 shares during the period. Mediolanum International Funds Ltd’s holdings in Clorox were worth $3,566,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in CLX. Invesco Ltd. boosted its holdings in shares of Clorox by 138.3% in the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock valued at $389,648,000 after buying an additional 1,883,465 shares during the last quarter. Norges Bank bought a new stake in Clorox during the second quarter worth $190,429,000. Arrowstreet Capital Limited Partnership lifted its stake in Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock valued at $149,983,000 after acquiring an additional 856,873 shares during the last quarter. Worldquant Millennium Advisors LLC bought a new position in shares of Clorox in the 2nd quarter valued at about $71,856,000. Finally, Nuance Investments LLC grew its position in shares of Clorox by 182.5% in the 2nd quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock valued at $101,832,000 after acquiring an additional 547,839 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $113.25 on Tuesday. The firm has a market cap of $13.81 billion, a P/E ratio of 17.78, a price-to-earnings-growth ratio of 0.56 and a beta of 0.59. The business’s 50 day moving average is $105.02 and its 200-day moving average is $114.06. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01. The Clorox Company has a 1-year low of $96.66 and a 1-year high of $161.45.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the prior year, the firm posted $1.86 EPS. The company’s revenue for the quarter was down 18.9% on a year-over-year basis. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 annualized dividend and a dividend yield of 4.4%. Clorox’s dividend payout ratio is 77.86%.

Analyst Ratings Changes

CLX has been the subject of several recent analyst reports. Wells Fargo & Company raised their target price on shares of Clorox from $108.00 to $115.00 and gave the company an “equal weight” rating in a research note on Friday, January 23rd. JPMorgan Chase & Co. cut their price objective on Clorox from $120.00 to $114.00 and set a “neutral” rating for the company in a research report on Friday, January 16th. TD Cowen reiterated a “hold” rating on shares of Clorox in a research note on Thursday, January 8th. Morgan Stanley decreased their target price on Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Finally, Barclays reaffirmed an “underweight” rating and set a $109.00 price target on shares of Clorox in a report on Friday, January 16th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Reduce” and an average price target of $120.33.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction on Friday, November 21st. The stock was acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the purchase, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.63% of the stock is owned by company insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.